
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 10 | 895.05 | 901.00 | 110 |
| 1 | 895.00 | 904.15 | 44 |
| 6 | 891.00 | 905.00 | 232 |
| 5 | 890.25 | 918.00 | 10 |
| 4 | 890.00 | 920.00 | 120 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 10 | 895.05 | 901.00 | 110 |
| 1 | 895.00 | 904.15 | 44 |
| 6 | 891.00 | 905.00 | 232 |
| 5 | 890.25 | 918.00 | 10 |
| 4 | 890.00 | 920.00 | 120 |
| 0 | Total | Total | 0 |
| Open | 905.20 |
| Previous Close | 900.80 |
| Volume | 29,654.00 |
| Value (Lacs) | 266.44 |
| VWAP | 895.29 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 11,023 |
| High | 905.20 |
| Low | 888.60 |
| UC Limit | 1,080.95 |
| LC Limit | 720.65 |
| 52 Week High | 1,251.00 |
| 52 Week Low | 850.00 |
| Face Value | 2.00 |
| All Time High | 1,335.10 |
| All Time Low | 370.00 |
| 20D Avg Volume | 275,709 |
| 20D Avg Delivery(%) | 21.86 |
| Book Value Per Share | -- |
| Dividend Yield | 0.56 |
| TTM EPS See historical trend | 0.00 (+25.08% YoY) |
| TTM PE See historical trend | -- (Average PE) |
| P/B See historical trend | 0.00 (Average P/B) |
| Sector PE | 40.10 |
*Delayed by 20 seconds.
Stock Score
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
3 out of 5 years Glenmark Life Sciences has given positive returns in November.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| November | 2.54% (2024) | 1.38% | -3.27% (2021) | -1.97% | 0.04% |
Alivus Life Sciences to Meet Investors/Analysts on Sept 2, 2025 Aug 26 2025 11:53 AM
Alivus Life Standalone June 2025 Net Sales at Rs 601.85 crore, up 2.25% Y-o-Y Aug 05 2025 12:06 PM
Stocks to Watch Today: ABB India, Dilip Buildcon, ITC, Railtel Corp, Hero MotoCorp, Delhivery, MCX, Muthoot Capital, Harsha Engineers in focus on 4 August Aug 04 2025 02:59 AM
Alivus Life Standalone March 2025 Net Sales at Rs 649.55 crore, up 21.05% Y-o-Y May 16 2025 10:35 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Alivus Life | 898.50 | -0.26 | 11,022.92 | 20.78 | 3.91 | 17.23 | -16.85 | 485 | 2,386 | 0.00 |
| Sun Pharma | 1,831.60 | 1.18 | 439,462.19 | 42.06 | 6.09 | 15.13 | 5.61 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,477.00 | -0.21 | 171,944.00 | 69.19 | 11.49 | 14.63 | 8.82 | 2,191 | 9,360 | 0.00 |
| Torrent Pharma | 3,720.60 | -0.26 | 125,922.01 | 58.84 | 16.78 | 25.17 | 16.16 | 1,911 | 11,516 | 0.40 |
| Cipla | 1,531.30 | 0.40 | 123,694.01 | 22.73 | 3.97 | 16.90 | 2.58 | 5,291 | 27,547 | 0.00 |